T. Rowe Price Associates »

Moonlake Immunot shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $140M 2.3M 60.39
2023-09-30 $121M 2.1M 57.00
2023-06-30 $99M 1.9M 51.00
2023-03-31 $18M 831k 21.39
2022-12-31 $8.6M 823k 10.50

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Federated Investors
Darwin Global Management
Holocene Advisors
Westfield Capital Management Company
Alliancebernstein
Fred Alger Management
Balyasny Asset Management
BlackRock
Caption Management
5AM Venture Management

View all funds holding Moonlake Immunot